Eyepoint Pharmaceuticals, Inc. (EYPT)

Last Three Months

26-Jan-24 -- 25-Apr-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Scientific & Technical Instruments

Electronics

Insider Trading Sentiment: Accumulate

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

19

0

6

+1

0

+2

0

+3

Two Year Chart

26-Apr-22 -- 25-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
02-Apr-24 5:27 PM View:	30-Mar-24 Payment of Exercise ($528.04K)	Paggiarino Dario A. Chief Medical Officer		Eyepoint Pharmaceuticals, Inc. - EYPT	84% 36.51K to 67.08K	0	0	--	--	Show Txns Hide Txns

13-Feb-24 5:38 PM View:	09-Feb-24 Payment of Exercise ($105.29K)	Jones David Scott SVP & Chief Commercial Officer		Eyepoint Pharmaceuticals, Inc. - EYPT	18% 37.96K to 44.92K	0	0	--	--	Show Txns Hide Txns

13-Feb-24 5:38 PM View:	09-Feb-24 Payment of Exercise ($91.93K)	Elston George Chief Financial Officer		Eyepoint Pharmaceuticals, Inc. - EYPT	21% 36.0K to 43.61K	0	0	--	--	Show Txns Hide Txns

13-Feb-24 5:40 PM View:	13-Feb-24 Gift 0	Lurker Nancy Executive Vice Chair Director		Eyepoint Pharmaceuticals, Inc. - EYPT	12% 187.65K to 210.24K	0	0	--	--	Show Txns Hide Txns

28-Feb-24 4:46 PM View:	27-Feb-24 Gift 0	Duker Jay S. President and CEO Director		Eyepoint Pharmaceuticals, Inc. - EYPT	19% 43.49K to 51.92K	0	0	--	--	Show Txns Hide Txns

22-Apr-24 4:00 PM View:	18-Apr-24 Purchase $10.49M	Cormorant Asset Management,... 10% Owner		Eyepoint Pharmaceuticals, Inc. - EYPT	8% 6.89M to 7.47M	0	0	--	--	Show Txns Hide Txns